JMIR Publications’ new article showcases the transformative potential of precision oncology
JMIR Publications today announced the release of a timely new article in its News and Perspectives section, showcasing…
Metformin mimics exercise-related metabolic effects in prostate cancer patients
A new study has found that metformin, a widely prescribed diabetes drug, may mimic one of exercise’s core…
PSMA therapy may postpone hormone treatment in prostate cancer patients
Where previous research showed that PSMA therapy for prostate cancer can prolong the lives of patients who have…
New AI Test Estimates Individualized Chemotherapy Benefit in Breast Cancer Patients
Ataraxis AI has launched Ataraxis Breast CTX, a predictive artificial intelligence (AI) test designed to estimate individualized chemotherapy…
Do GLP-1 Drugs Reduce Cancer Risk or Increase It?
IntroductionHow do GLP-1RAs work?The relationship between obesity and cancerWhat current research shows about GLP-1 drugs and cancer riskConflicting…
UMGCCC awarded $3 million to train the next generation of oncology researchers
The University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC) has been awarded a prestigious $3 million National…
Can AI chatbots help brain tumor patients understand their care?
AI tools could transform how brain tumor patients access and understand critical care information, but without careful oversight,…
Immunotherapy plus chemotherapy improves outcomes in stage III dMMR colon cancer
A new study from researchers at the Alliance for Clinical Trials in Oncology (Alliance) shows that patients with…
Systematic review identifies stress-induced biological triggers in oncology
Stress is a constant companion in the oncologist’s office. It appears at the time of diagnosis, increases with…
Webinar introduces advanced bioinformatics tool to interpret mutations in cancer genomes
A free open-access webinar will introduce the Cancer Genome Interpreter (CGI), an advanced bioinformatics tool to interpret mutations…
Novartis agrees to acquire a pan-mutant-selective PI3Kα inhibitor, strengthening its breast cancer pipeline
Proposed acquisition supports the Novartis oncology strategy in hormone receptor positive, human epidermal growth factor receptor two-negative (HR+/HER2-)…
Study reveals new dual role of ezrin in osteosarcoma
Scientists at Georgetown University’s Lombardi Comprehensive Cancer Center have uncovered a new dual function for a well-known cancer-related…